Eden Research Plc · LSE:EDEN
Eden Research — Shareholder Meeting (June 2023)
37 slides from Eden Research's shareholder meeting presentation, Jun 29, 2023
Slide 1: Eden Research plc 2023 Annual General Meeting
Eden Research plc 2023 Annual General Meeting 29th June 2023 7-9 Tokenhouse Yard London
Slide 2: Eden Research plc is an AIM-quoted company
Eden Research plc is an AIM-quoted company focused on sustainable biopesticides and plastic-free encapsulation technology for use in the global crop protection, animal health and consumer products industries.
Slide 3: About Us / Key statistics
About Us Key statistics Eden is the only UK quoted (AIM: EDEN) company focused on biopesticides for sustainable agriculture • Intellectual property and expertise in plant-derived sustainable chemistry 21 Countries have granted and delivery technologies Consumer product authorisation products • Prove
Slide 4: The Drive Towards Sustainable Agriculture
The Drive Towards Sustainable Agriculture Farming practices which Embracing farming maintain yields while reducing practices that mimic natural harm to the environment ecological processes Eden formulations are A reflection of society’s Pressure on productivity driven well suited for a wide range of
Slide 5: Significant Market Potential
Significant Market Potential Crop protection products formulated with $11bn Sustaine® and Eden’s active ingredients The global biopesticides market is projected to be worth more than $11 billion by 2027 can help address many of these issues: 15% per annum The biopesticides market is growing at a Con
Slide 6: Our Products
—_— —_— —— —— LL Loe THE NATURAL SOLUTION Our Products
Slide 7: Our Product Focus
Our Product Focus Our focus is on developing products based on sustainable chemistries to protect crops from pests and disease, with equal or better performance when compared with conventional pesticides. FUNGICIDES NEMATICIDES INSECTICIDES SEED TREATMENTS Botrytis, powdery Root knot Mites and Multi
Slide 8: Product Characteristics
Product Characteristics Enabling sustained Tackling Solvent-free, stable Protecting plants Polymer-free ‘Residue Low or no delivery, increasing resistance formulations with from potentially formulation free’ pre-harvest intervals residual efficacy and build-up high loadings of damaging chemicals tec
Slide 9: Introducing Ecovelex™
—_— —_— —— —— LL Loe THE NATURAL SOLUTION Introducing Ecovelex™
Slide 10: Ecovelex™ Bird repellent seed treatment
Ecovelex™ Ecovelex™ Bird repellent seed treatment Current status Background Semi-field studies have shown good efficacy Ecovelex is a biological bird repellent seed treatment initially for use on maize. Field trials, undertaken by both parties, showed efficacy and Two incumbent ingredients used in p
Slide 11: Ecovelex bird repellent seed treatment features
covelex’ f @ Water based, does not contain solvents BIRD REPELLENT SEED TREATMENT @ Does not contain any candidates for substitution 4 “ @ Does not contain any Beh 8 nanomaterials P @ Does not contain any polymers or microplastics @ Efficacy proven in field “Don't eat me because studies you won't li
Slide 12: Seed Treatments
Seed Treatments What are Seed Treatments? Physical, biological or chemical agents applied to seeds to provide protection and help improve overall crop performance Multiple functions: supporting greater uniformity of seed germination, plant height, vigour and biomass by protecting against pathogens a
Slide 13: Bird Damage in Maize
Bird Damage in Maize Missing plants caused by birds picking seeds Plant pulled out by birds to eat remaining cotyledon
Slide 14: Ecovelex™ - The Biological Bird Repellent Seed Treatment
Ecovelex™ - The Biological Bird Repellent Seed Treatment
Slide 15: Ecovelex™ Efficacy (%)
Ecovelex™ - The Biological Bird Repellent Seed Treatment % Efficacy BBCH 10 (6-29 days after drilling)- Summary of 16 trials 45 40 38.3 36.6 35 30 Efficacy (%) 25 20 15 10 5 0 Untreated Korit Ecovelex (% missing and damaged (0.6L/100kg seeds) (0.71L/100kg seeds) plants)
Slide 16: Commercial Product Update
—_— —_— —— —— LL Loe THE NATURAL SOLUTION Commercial Product Update
Slide 17: Mevalone® Biofungicide
Mevalone® Biofungicide Background Current status Mevalone is a foliar biofungicide which was Approved in Southern EU on a wide range of targets and crops developed initially to target botrytis on grapes. Approved in Kenya and Australia Since its launch in the EU in 2016, the label for Approval in th
Slide 18: Clear results, robust efficacy
INCIDENCE OF DISEASE (%) Average of 13 trials across southern Europe Clear results 82.3% § Mevalone® is a proven product § A reliable alternative to conventional control § Phased release for prolonged effects 29.5% 27.1% 18.1% § Easy to use and apply Untreated Control Conventional 1 Conventional 2 M
Slide 19: Cedroz™ Bio-nematicide
Cedroz™ Bio-nematicide Background Current status Cedroz is a bio-nematicide targeting Approved in Southern and Central EU on a wide range root-knot nematodes in high value crops. of high-value crops A development and commercialisation Approval in the US received in September 2022 agreement was signe
Slide 20: CEDROZ post-planting nematicide
CEDROZ post-planting nematicide Severity of root damage, Zeck scale 0-10 ro) Wi Specimen 3.45 3.35 Test1 i Cedroz Test 2 @ Standard Test 3 % cumulative production compared to the untreated, which = 100 M@CedrozL/ha Mi Vydate’ 10L 136.9 133.9 408.4 1610-1172 \] : l L Test 1 Test 2 Test 3
Slide 21: Developing Opportunities
—_— —_— —— —— LL Loe THE NATURAL SOLUTION Developing Opportunities
Slide 22: Positive Outlook for Growth
Positive Outlook for Growth How growth will be achieved The team at Eden now has the necessary capabilities to formulate, develop, test (up to pot plant level) and register products that it has created. Label extensions and country approvals of Mevalone and Cedroz continue to increase, which directl
Slide 23: Downy Mildew: Filling a gap in the market
Downy Mildew Filling a gap in the market Background Current status Due to the recent restriction of a number Second year regulatory field trials are complete of key downy mildew products, there is a with good results received. strong need for replacement products. Corteva has been appointed as our n
Slide 24: Insecticide: Significant opportunities for effective, new products
Insecticide Significant opportunities for effective, new products Background Current status Due to a ban on numerous insecticides, Initial data received from the field trials undertaken in 2022 shows such as neonicotinoids, there is an good efficacy, consistent with that in 2021 opportunity for effe
Slide 25: Insecticide
Insecticide HT Efficacy (%) against Spider mite - Adult (Summary of 4 trials, error bars = standard error, 4 applications at 7-day interval) 100 90 80 70 60 50 40 30 20 10 ) INO20E 8.9 L/ha CS (Flipper) mDA-A mDA-B mDA-C mDA-D m14+DA-D
Slide 26: Sustaine® Projects: Addressing the rising microplastics issue
Sustaine® Projects Addressing the rising microplastics issue Background Current status In addition to using microencapsulation Field trials underway with multiple industry partners. system, Sustaine, in our in-house developed products, such as Mevalone and Cedroz, Decisions regarding future evaluati
Slide 27: Significant Additional Growth Opportunities
Significant Additional Growth Opportunities Evaluations in additional areas of significant commercial potential include: Cannabis • Black sigatoka (banana) • Potato blight Eden has been approached by a new potential partner to see if Mevalone, or any other Eden formulation, would be suitable to targ
Slide 28: Regulatory and Commercial Status
Regulatory and Commercial Status
Slide 29: Regulatory Position
Regulatory Position EFSA (EU) Organic (EU) • Application for the renewal of Eden’s three • All three of Eden’s active ingredients have active ingredients (eugenol, geraniol and thymol) been approved as inputs for organic has been submitted to EFSA for its review. agriculture in the EU. • The renewed
Slide 30: Commercial Footprint
Commercial Footprint Our presence in Europe grew in 2021-22 through new authorisations for both Cedroz™ and Mevalone®, and we anticipate further approvals in Europe and further abroad in 2023. Our US EPA approval for the sale of Mevalone® and CedrozTM was granted in September 2022. Commercial Approv
Slide 31: Strategy and Innovation
—_— —_— —— —— LL Loe THE NATURAL SOLUTION Strategy and Innovation
Slide 32: Our Strategy
Our Strategy Research, Business line Commercial Strengthening and development diversification growth growing the team and operations • Pursuit of opportunities in seed • Supply chain optimisation • Regulatory clearance in new • Added capacity in R&D, including treatments • Expansion of in-house scre
Slide 33: Innovation Capacity
Innovation Capacity Development of Laboratories are Eden’s product in-house R&D – now GLP-ready and development platform reduces dependency operating to this consists of three on 3rd parties, standard adding registered active CROs, etc. In-house capabilities credibility and Costs partially offset in
Slide 34: Financials and news-flow
—_— —_— —— —— LL Loe THE NATURAL SOLUTION Financials and news-flow
Slide 35: 2022 Financial Highlights
2022 Financial Highlights 2022 2021 audited audited Notes: Revenue £1.8m £1.2m § Revenue for the year increased by approximately 50% to £1.8m, £0.1m, or 6%, ahead of market expectations Product sales revenue £1.6m £1.1m of £1.7m (FY2021: £1.2m) Other revenue £0.2m £0.1m § Product sales increased by
Slide 36: Newsflow: Recent and Coming up
Newsflow Recent • US EPA national approval received for Mevalone®, Cedroz™ and three active ingredients in 2022 • Initial US state approvals received in 2022 with additional approvals expected in 2023 • First sale of Mevalone to Sipcam Agro USA made in December 2022 in support of commercial sales in
Slide 37: Thank you
THE NATURAL SOLUTION Thank you